IndraLab

Statements



reach
"56 On the other hand, we discovered that STAMBP could raise the risk of spondylolisthesis/spondylolysis."

reach
"STAM binding protein (STAMBP) and T-cell surface glycoprotein CD6 isoform (CD6 isoform) can increase the risk of spondylolisthesis/spondylolysis, whereas monocyte chemoattractant protein 2 (MCP2) and latency-associated peptide transforming growth factor beta 1 (LAP-TGF-beta1) can decrease spondylolisthesis/spondylolysis risk."